Marc Le Borgne

Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2

Jean Guillon, Marc Le Borgne, Charlotte Rimbault et al. · European Journal of Medicinal Chemistry · 2013 · 109 citations

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +9

Cobalt–Chromium Dental Alloys: Metal Exposures, Toxicological Risks, CMR Classification, and EU Regulatory Framework

Alina Vaicelyte, Christine Janssen, Marc Le Borgne et al. · Crystals · 2020 · 95 citations · Full text

Cmr Classification, Engineering, Operative Dentistry +16

Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors

Claas Hundsdörfer, Hans‐Jörg Hemmerling, Claudia Götz et al. · Bioorganic & Medicinal Chemistry · 2012 · 88 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +5

Converting Potent Indeno[1,2-<i>b</i>]indole Inhibitors of Protein Kinase CK2 into Selective Inhibitors of the Breast Cancer Resistance Protein ABCG2

Gustavo Jabor Gozzi, Zouhair Bouaziz, Evelyn Winter et al. · Journal of Medicinal Chemistry · 2014 · 77 citations · Full text

Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: Potent and selective aromatase inhibitors

Marie-Pierre Lézé, Marc Le Borgne, Patrícia Recordon-Pinson et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 71 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +10